Sofie Derijcke

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

Marina Chiara Garassino, Byoung Chul Cho, Joo-Hang Kim et al. · The Lancet Oncology · 2018 · 568 citations · Full text

Medicine, Immunology, Pathology +5

UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)

Jair Bar, Nir Peled, Shiruyeh Schokrpur et al. · Journal of Thoracic Oncology · 2022 · 92 citations · Full text

Does nivolumab for progressed metastatic lung cancer fulfill its promises? An efficacy and safety analysis in 20 general hospitals

Kurt G. Tournoy, Michiel Thomeer, Paul Germonpré et al. · Lung Cancer · 2017 · 44 citations

Oncology, General Hospitals, Cancer Management +5

Coping Strategy Influences Quality of Life in Patients With Advanced Lung Cancer by Mediating Mood

Mick van de Wiel, Sofie Derijcke, D. Galdermans et al. · Clinical Lung Cancer · 2020 · 31 citations · Full text

Palliative Care, Quality Of Life, Life Satisfaction +13

Validation of the Freund Clock Drawing Test as a screening tool to detect cognitive dysfunction in elderly cancer patients undergoing comprehensive geriatric assessment

Michelle Lycke, Lore Ketelaars, Tom Boterberg et al. · Psycho-Oncology · 2014 · 25 citations · Full text